Study Design. Systematic review. Objective. To establish the ability of the Orebro Musculoskeletal Pain Questionnaire (OMPQ) to predict outcome in patients with recent onset spinal pain.
The majority of health care costs associated with spinal pain are incurred in the management of patients with chronic pain. 1, 2 There is some evidence to suggest that psychosocial factors are important in the progression from an acute to a chronic pain problem. [2] [3] [4] The Orebro Musculoskeletal Pain Questionnaire (OMPQ) was developed as a simple tool to allow a primary care practitioner to screen for psychosocial "yellow flags." The OMPQ is used to provide patient-specific estimates of prognosis and to direct therapy. [5] [6] [7] Clinical guidelines such as the New Zealand guidelines for acute low back pain 8 and the New South Wales WorkCover guidelines for management of soft tissue injuries, 9 recommend the use of the OMPQ to screen for people at risk of delayed recovery. Despite these guidelines recommending its use, the predictive validity of this questionnaire has not been systematically reviewed. Therefore, the aim of this review was to investigate the ability of the OMPQ to predict long-term outcome in patients with recent onset spinal pain.
Materials and Methods

Search Strategy
MEDLINE, Pre-MEDLINE, CINAHL, EMBASE, Pubmed, PsychINFO, PEDro, SportDiscus, Cochrane Central Register of Clinical Trials and Cochrane Database of Systematic Reviews were searched from the earliest record available up to September 2007. The search strategy is detailed in Appendix A. Personal files were searched and reference lists of all potential papers were searched to identify studies missed by the electronic search process. Studies citing the included articles were also identified using the Science Citation Index.
Eligibility Criteria
A study was included if it fulfilled all of the following criteria:
1. The study population included subjects described as having acute or subacute spinal pain (with or without pain radiating down the leg) of no specific cause. Studies that included subjects with previous spinal pain problems were included, as recurrences are common, 10 and thus this reflects many of the usual patients seeking health care for spinal pain. 2. Study participants completed the Orebro Musculoskeletal Pain Questionnaire at baseline when they first entered the study. 3. The study included at least one of the following outcome measures: measures of pain, disability, sick leave, and/or self-rated recovery using a global perceived effect scale at follow-up. 4. The study design was prospective (either cohort studies or clinical trials). Studies with participants receiving conservative treatment from primary health care professionals (general practitioners, physiotherapists, and chiropractors) were included. 5. Source of participants and method of sampling were described. 6. The article was available in English.
Studies were excluded that recruited patients with "red flag" conditions such as fracture, arthritis, infection, tumor, cauda equina syndrome, ankylosing spondylitis, or other inflammatory diseases. Studies that recruited pregnant women were also excluded.
Assessment of Methodologic Quality
Although there is no widely accepted method for assessing methodologic quality of prognosis studies and there is little empirical evidence of bias related to various methodologic features of such studies, validity criteria have been proposed. 11 Methodologic quality of the included studies was assessed by 7 criteria (Table 1) . These criteria have been used in previous prognostic reviews of musculoskeletal disorders. 10, 12 Two reviewers independently assessed the quality of included studies and any disagreements were resolved by consensus.
Data Extraction and Analysis
Study characteristics extracted from eligible papers were target population, sample size, duration of pain at time of enrolment (if stated in paper), description of interventions, duration of follow-up, outcome measures and measures of the predictive ability of the OMPQ. Outcome data extracted were pain, functional disability, sick leave, and global recovery.
Where possible, areas under the receiver operator characteristic curve (AUC) with 95% confidence intervals (CI) were extracted from papers or calculated by the authors from primary data provided in the original papers. The AUC value can be interpreted as the probability of correctly predicting outcome for randomly selected pairs of people who did and did not eventually recover. The AUC varies from 0.5 (prediction no better than chance) to 1.0 (perfect prediction).
Receiver operator characteristic (ROC) curves were generated by plotting true-positive rates (sensitivity) against falsepositive rates (1-specificity) using data reported in articles for different cut-off scores of the OMPQ. AUCs with 95% CIs were calculated using the Statistical Package for the Social Sciences version 15.0. In 2 studies, 6, 13 sensitivity values for 1-30 and greater than 30 days of sick leave for each reported OMPQ cut-off score were combined to form one sensitivity value for each cut-off score. These calculated sensitivity values were used along with specificity values reported in the studies, to generate the ROC curves used to establish the ability of OMPQ scores to predict subjects who took sick leave in the past 6 months due to back or neck pain.
Crude odds ratios with 95% CIs were extracted for one data set. 14, 15 Outcome measures were assessed and recovery defined differently across studies, making pooling across studies problematic. Therefore, no attempt to pool statistics on predictive ability of the OMPQ was made. A second reviewer checked the data extraction. Reviews 8) . After the first screening, 823 nonduplicate titles were selected and after reading the title and/or abstracts, 29 full publications were retrieved ( Figure 1 ). Another 3 citations were added by checking the references of the 29 full publications, resulting in a total of 32 potential papers. Seven publications (with 5 discreet data sets) fulfilled all inclusion criteria and were included in this review.
Results
Selection of Studies
Methodologic Quality
Two reviewers scored quality criteria for the 7 included studies (total of 49 quality criteria) and agreed on 41 (85%). Results of the quality assessment are presented in Table 1 . The initial inter-rater agreement was 71% for defined sample, 86% for representative sample, 100% for inception cohort, 100% for complete follow-up, 100% for prognosis, 86% for blinded outcome and 43% for statistical adjustment. All studies defined the sample. Three studies (43%) specifically described methods for recruiting a representative sample. 13, 16, 17 Three publications (1 data set) recruited an inception cohort 14, 15, 18 and all had follow-up of at least 80%. All publications quantified prognosis and reported prognostic factors. One study (14%) 14 used blinded assessment and all studies performed statistical adjustment for prognostic factors. Data Extraction Study design, subject characteristics, setting, outcome measures, and durations of follow-up of the included studies are summarized in Table 2 . One data set was described in more than one publication. 14, 15, 18 Of the 5 discreet data sets, only two 6,13 included patients with back and neck pain and 3 included patients with low back pain. 14 -18 One data set included only patients who contacted a primary care practitioner for the first time due to acute low back pain. 14, 15, 18 The studies included were all cohort studies, with interventions by primary health care clinics, 6 physiotherapists, 16 general practitioners, 17 or a combination of the latter two. 13 In one study, 14, 15, 18 patients with acute low back pain were provided with information according to clinical guidelines for acute low back pain after the baseline assessment and were able to contact a health care provider if they needed to during the study period. Patients were recruited through presentation to general practitioners 16, 17 or through a variety of primary health care providers 6, [13] [14] [15] 18 and/or newspaper advertisements. 14, 15, 18 Reported AUCs were extracted from 3 studies 16 -18 and were calculated from primary data provided in studies. 6, 13 The ability of the OMPQ to predict persisting pain and disability were reported in two 13, 18 and four [13] [14] [15] 18 studies, respectively. The ability of this questionnaire to predict sick leave was evaluated in 3 studies 6, 13, 18 and AUC values for predicting global recovery were extracted from 2 studies.
16,17
Course of Spinal Pain
Three studies reported on pain intensity during the follow-up period. [13] [14] [15] Grotle et al 15 reported there was a mean reduction in pain intensity of 53% during the first month and 58% during the first 3 months.
14 One study reported the proportion of subjects who had recovered (as measured by pain intensity), was 52% at 6 months. 13 Three studies reported on disability levels at follow- up. [13] [14] [15] The proportion of subjects who had recovered (as measured by disability levels), ranged from 40% at 6 months 13 to 83% at 12 months. 15 Two studies reported amount of sick leave as a result of pain. 6, 13 The proportion of subjects who reported taking more than 30 days sick leave due to pain ranged from 17% 13 to 18% 6 during the 6-month follow-up period.
Predictive Ability of the Orebro Musculoskeletal Pain Questionnaire
Pain. Two studies 13, 18 reported the ability of OMPQ scores to predict persistent pain problems (Table 3) . Reported AUCs (95% CI) for persistent pain (score of greater than 2 out of 10 on a numerical rating scale) were 0.62 (0.51-0.73) at 6 months and 0.70 (0.60 -0.80) at 12 months follow-up, in a cohort of patients with acute low back pain of less than 3 weeks duration. 18 In one study, 13 an experienced pain index was created from 2 items of the OMPQ by multiplying average pain intensity during the last 3 months (scored out of 10) by pain frequency (scored out of 10). The calculated AUC (95% CI) for persistent pain (score of greater than 17 out of 100 on the experienced pain index) was 0.75 (0.66 -0.85) at 6 months, in a sample of patients with spinal pain of less than 3 months duration.
13
Disability. Four studies [13] [14] [15] 18 (2 data sets) reported the ability of OMPQ scores to predict persisting disability (Table 3) . Reported AUCs (95% CI) for disability score of greater than 4 on the Roland Morris Disability Questionnaire (RMDQ) were 0.68 (0.56 -0.80) at 6 months and 0.72 (0.60 -0.84) at 12 months follow-up, in patients with acute low back pain. 18 The calculated AUC (95% CI) for disability (total score of less than 45 out of 50 on 5 questions of OMPQ which measure activities of daily living) was 0.83 (0.75-0.91) at 6 months, in a sample of patients with acute or subacute spinal pain. 13 Grotle et al 14 reported there was a 4.66 (95% CI, 1.9 -11.46) times higher chance of persisting disability (RMDQ score greater than 4) at 3 months follow-up in medium-high risk patients (OMPQ score greater than or equal to 90), compared to low risk patients (OMPQ score less than 90). Also, there was a 6.54 (95% CI, 1.83-23.36) times greater chance of disability (RMDQ score greater than 4) at 12 months follow-up in high risk patients (OMPQ score greater than or equal to 112), compared to low-medium risk patients (OMPQ score less than 112). 15 Though, the 95% CIs for these crude odds ratios were very wide (Table 3 ).
Sick Leave. Three studies reported the ability of OMPQ scores to predict sick leave (Table 3) . 6, 13, 18 Reported AUCs (95% CI) for identifying a patient who had more than 30 days off work due to pain were 0.80 (0.66 -0.93) at 6 months and 0.72 (0.57-0.86) at 12 months followup, in patients with acute low back pain. 18 Calculated AUCs (95% CI) for predicting patients who took sick leave due to pain were 0.82 (0.74 -0.89) 6 and 0.74 (0.64 -0.84) 13 at 6 months, in 2 samples of patients with acute and subacute spinal pain.
Global Recovery. Two studies reported the ability of OMPQ scores to predict self-reported global nonrecovery (Table 3) . 16, 17 Reported AUC (95% CI) for prediction of self-rated recovery at 12 weeks was 0.64 (0.50 -0.79), in a sample of patients with acute and subacute low back pain. 16 The calculated AUC (95% CI) for prediction of nonrecovery as defined by a score of "slightly improved" or worse at 2 or more follow-up time points (6, 13, 26 and 52 weeks) was 0.61 (0.54 -0.67), in a sample of patients with low back pain of less than 12 weeks duration.
17
Discussion
This is the first time that the predictive ability of the OMPQ has been systematically reviewed, despite clinical guidelines recommending its use in both patients with acute low back pain 8 and in workers compensation patients with soft tissue injuries. 9 The review located 5 relevant data sets from studies of variable methodologic quality. These data support the view that the OMPQ has moderate predictive ability in determining long-term pain, disability and sick leave in patients with acute or subacute spinal pain. These data also suggest that OMPQ scores have poorer predictive ability in determining self-reported global recovery.
The methodologic shortcomings do raise some questions about the veracity of the results. The main methodologic weaknesses were a failure to enrol a representative sample, lack of recruitment of an inception cohort and lack of blinding. If an inception cohort is not enrolled, patients who recovery quickly are not included and this results in some uncertainty about the OMPQ's ability to correctly predict outcome in such patients. However, we decided to include studies who did not recruit an inception cohort, because of the small number of published studies which provide evidence of the OMPQ's ability to predict outcome in patients with recent onset spinal pain. Also, the lack of blinding is a particular concern, with only one study 14 explicitly mentioned that assessors who measured outcome were blinded to baseline OMPQ scores. Bias could be introduced into the study if personnel measuring outcome are aware of baseline OMPQ scores.
A difficulty we faced was that we could only judge study quality based on the report of the study. While reporting guidelines for clinical trials (the Consort statement 19 ) have existed for over a decade, guidelines for reporting observational studies (the STROBE statement 20 ) were only released in October 2007. It may be that a failure to report critical study details has meant that we have underestimated study quality.
In 2 studies, 6,13 data for 1 to 30 and greater than 30 days of sick leave were combined to form one cut-off for taking sick leave. While collapsing data in this way loses information, it was the most practical way of allowing calculation of an AUC to establish predictive ability using available data. However, this does not allow for differentiation of the predictive ability of the OMPQ to detect patients who will take a few days versus long-term sick leave. This information would be useful, as a patient who recovers well may take a few days sick leave as a result of their injury. §Self-rated recovery at 12 wk assessed using a dichotomized question (recovered or not). ¶Self-rated recovery assessed using a 7 point global perceived effect scale and non-recovery defined as a score of 'slightly improved' or worse at 2 or more follow-up time points (6, 13, 26 and 52 wk).
Sick leave during the follow-up period due to spinal pain. **Non-recovery defined as score Ͼ17 out of 100 on the experienced pain index. This index was created from two items of the Orebro Musculoskeletal Pain Questionnaire (OMPQ) by multiplying average pain intensity during the last 3 mo (scored out of 10) by pain frequency (scored out of 10). † †Non-recovery defined as total score Ͻ45 out of 50 on 5 questions of OMPQ which measure activities of daily living. ‡ ‡Association between non-recovery (RMDQ score Ͼ4) and baseline OMPQ scores analyzed as crude OR (95% CI) for medium-high risk (OMPQ score Ն90) compared to low risk group (OMPQ score Ͻ90). § §Association between non-recovery (RMDQ score Ͼ4) and baseline OMPQ scores analyzed as crude OR (95% CI) for high risk group (OMPQ score Ն112) compared to low-medium risk group (OMPQ Ͻ112).
The majority of studies we located were small and provided imprecise estimates of predictive ability. For example, Grotle et al reported 95% CIs for odds ratios of 1.9 to 11.46 at 3 months 14 and 1.83 to 23.36 at 12 months 15 follow-up, clearly not as precise as would be preferred. Future studies need to enrol much larger numbers of subjects to provide more precise estimates of the predictive ability of the OMPQ. Alternatively, if authors provided individual subject data, it could be pooled to provide a more accurate estimate of predictive ability of the Orebro.
The included studies were conducted in different parts of Scandinavia 6, [13] [14] [15] 18 and the Netherlands. 16, 17 These study populations are probably quite homogenous. However, psychosocial risk factors may operate differently in other social, ethnic and cultural groups. Thus, to determine whether the OMPQ has the same predictive ability in many different settings, studies should be conducted on cohorts from Oceania, Asia, the United States and different parts of Europe. Research of this nature will provide further evidence to allow a more accurate determination of the OMPQ's external validity.
The area under the ROC curve was used where possible, as this statistic provides an overall measure of predictive ability across a range of cut-off points. Previous studies have suggested optimal cut-off points between 90 13,18 and 105 6 for prediction of chronicity. These cutoffs were based on minimizing misclassification error but there are additional considerations in clinical practice. There are a range of clinical scenarios where the consequences of misclassification may be quite different. For example, if the objective is not to miss any patients likely to develop persistent problems, the cut-off score may be reduced. In contrast, if patients at risk of delayed recovery are to be offered an expensive intervention program to assist in preventing chronicity, the score may be increased to reduce false positives. 7 We would encourage authors to report measures of accuracy for each cut-off point, as this would allow practitioners to choose a cutoff point that is relevant to their clinical situation.
Studies report moderate predictive ability of total OMPQ scores to predict delayed recovery. However, there is a paucity of literature available which considers the predictive ability of certain subscales or items of the OMPQ. Heneweer et al 16 reported on the predictive ability of the total score and different subscales of the OMPQ in determining self-rated recovery at twelve weeks. As the reported AUC for the total score (0.64 95% CI, 0.50 -0.79) was poorer than for the pain subscale (0.82 95% CI, 0.71-0.93) it is possible that some subscales are not as useful in predicting outcome. This result suggests that it may be fruitful to revise the OMPQ by deleting less predictive items or revising the items to improve prediction.
To date only a few studies have attempted to establish which OMPQ items have the highest predictive value in determining future pain, disability and sick leave. 6, 13, 18 This research assists in determining which items are most useful in predicting future outcomes and whether some items are irrelevant and need to be removed from the OMPQ. However, further research, in the form of large prospective cohort studies, are needed to confirm whether certain items or subscales have greater ability to establish risk of delayed recovery in different patient populations. This will assist in refinement of the questionnaire to improve its predictive ability and usefulness.
In conclusion, the OMPQ has moderate predictive ability in identifying patients with spinal pain at risk of developing chronic pain, disability or taking long-term sick leave. This evidence supports the recommendations of clinical guidelines which suggest its use in identifying patients with psychosocial risk factors who require further clinical assessment and/or early intervention to prevent the development of persistent problems. However, practitioners need to be aware of the OMPQ's limitations and that it will not correctly classify all patients. Also, further research in the form of large high quality cohort studies, is needed to confirm the predictive ability of individual items and total scores in different populations and settings. This will provide direction for improvement of the OMPQ and enhance its usefulness in assisting practitioners to effectively use resources, by only providing preventative intervention strategies to patients truly at risk of delayed recovery.
Key Points
• The Orebro Musculoskeletal Pain Questionnaire has been promoted as a tool to screen for psychosocial factors associated with delayed recovery.
• To date no study has systematically reviewed the Orebro questionnaire.
• This systematic review shows the Orebro questionnaire has moderate predictive ability in identifying patients with spinal pain at risk of delayed recovery.
• Further research is needed to confirm the predictive ability of different items of the questionnaire and provide direction for its improvement to enhance its usefulness.
